J 2019

A Single Conserved Amino Acid Residue as a Critical Context-Specific Determinant of the Differential Ability of Mdm2 and MdmX RING Domains to Dimerize

KOSZTYU, Pavlína, Iva SLANINOVÁ, Barbora VALČÍKOVÁ, Amandine VERLANDE, Petr MÜLLER et. al.

Basic information

Original name

A Single Conserved Amino Acid Residue as a Critical Context-Specific Determinant of the Differential Ability of Mdm2 and MdmX RING Domains to Dimerize

Authors

KOSZTYU, Pavlína (203 Czech Republic, belonging to the institution), Iva SLANINOVÁ (203 Czech Republic, belonging to the institution), Barbora VALČÍKOVÁ (203 Czech Republic, belonging to the institution), Amandine VERLANDE (250 France, belonging to the institution), Petr MÜLLER (203 Czech Republic), Jan PALEČEK (203 Czech Republic, belonging to the institution) and Stjepan ULDRIJAN (203 Czech Republic, guarantor, belonging to the institution)

Edition

Frontiers in Physiology, Lausanne, Frontiers Media, 2019, 1664-042X

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30105 Physiology

Country of publisher

Switzerland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 3.367

RIV identification code

RIV/00216224:14110/19:00108048

Organization unit

Faculty of Medicine

UT WoS

000463960200001

Keywords in English

Mdm2; Mdm4; MdmX; RING domain ubiquitin protein ligase; dimerization; mutagenesis; E3; p53

Tags

International impact, Reviewed
Změněno: 31/3/2020 22:09, Mgr. Pavla Foltynová, Ph.D.

Abstract

V originále

Mdm2 and MdmX are related proteins serving in the form of the Mdm2 homodimer or Mdm2/MdmX heterodimer as an E3 ubiquitin ligase for the tumor suppressor p53. The dimerization is required for the E3 activity and is mediated by the conserved RING domains present in both proteins, but only the RING domain of Mdm2 can form homodimers efficiently. We performed a systematic mutational analysis of human Mdm2, exchanging parts of the RING with the corresponding MdmX sequence, to identify the molecular determinants of this difference. Mdm2 can also promote MdmX degradation, and we identified several mutations blocking it. They were located mainly at the Mdm2/E2 interface and did not disrupt the MdmX-Mdm2 interaction. Surprisingly, some mutations of the Mdm2/E2 interface inhibited MdmX degradation, which is mediated by the Mdm2/MdmX heterodimer, but did not affect p53 degradation, mediated by the Mdm2 homodimer. Only one mutant, replacing a conserved cysteine 449 with asparagine (C449N), disrupted the ability of Mdm2 to dimerize with MdmX. When we introduced the cysteine residue into the corresponding site in MdmX, the RING domain became capable of forming dimers with other MdmX molecules in vivo, suggesting that one conserved amino acid residue in the RINGs of Mdm2 and MdmX could serve as the determinant of the differential ability of these domains to form dimers and their E3 activity. In immunoprecipitations, however, the homodimerization of MdmX could be observed only when the asparagine residue was replaced with cysteine in both RINGs. This result suggested that heterocomplexes consisting of one mutated MdmX RING with cysteine and one wild-type MdmX RING with asparagine might be less stable, despite being readily detectable in the cell-based assay. Moreover, Mdm2 C449N blocked Mdm2-MdmX heterodimerization but did not disrupt the ability of Mdm2 homodimer to promote p53 degradation, suggesting that the effect of the conserved cysteine and asparagine residues on dimerization was context-specific. Collectively, our results indicate that the effects of individual exchanges of conserved residues between Mdm2 and MdmX RING domains might be context-specific, supporting the hypothesis that Mdm2 RING homodimers and Mdm2-MdmX heterodimers may not be entirely structurally equivalent, despite their apparent similarity.

Links

GA14-12166S, research and development project
Name: Regulace dráhy nádorového supresoru p53 novými vazebnými partnery onkogenů Mdm2 a Mdm4
Investor: Czech Science Foundation
MUNI/A/0754/2017, interní kód MU
Name: Buněčná a molekulární biologie
Investor: Masaryk University, Category A
MUNI/A/1087/2018, interní kód MU
Name: Molekulární a buněčná biologie pro biomedicínské vědy
Investor: Masaryk University, Category A
MUNI/M/0822/2015, interní kód MU
Name: Expressive Visualization of Protein Complexes
Investor: Masaryk University, INTERDISCIPLINARY - Interdisciplinary research projects